- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01114269
Estudio de cohorte PREDETERMINADO
PRE-DETERMINE: Marcadores biológicos y estudio de cohorte MRI SCD
This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.
Descripción general del estudio
Estado
Descripción detallada
The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Alberta
-
Edmonton, Alberta, Canadá, T6G 2B7
- University of Alberta
-
-
British Columbia
-
Vancouver, British Columbia, Canadá, V5Z 1M9
- Vancouver General Hospital
-
-
Ontario
-
Mississauga, Ontario, Canadá, L5B 2P7
- Mississauga Clinical Research Centre
-
-
-
-
Alaska
-
Anchorage, Alaska, Estados Unidos, 99508
- Alaska Heart Institute
-
-
Arizona
-
Glendale, Arizona, Estados Unidos, 85306
- Phoenix Heart, PLLC
-
Phoenix, Arizona, Estados Unidos, 85032
- Cardiovascular Consultants
-
-
California
-
Banning, California, Estados Unidos, 92220
- Beaver Medical Group/Clinical Care Research
-
-
Colorado
-
Colorado Springs, Colorado, Estados Unidos, 80909
- Memorial Health System
-
Denver, Colorado, Estados Unidos, 80204
- Colorado Heart and Vascular
-
-
Florida
-
Brandon, Florida, Estados Unidos, 33511
- Bay Area Cardiology Associates, P.A.
-
Gainesville, Florida, Estados Unidos, 32610
- University of Florida - Gainsville
-
Miami, Florida, Estados Unidos, 33135
- Reliable Clinical Research
-
Miami Beach, Florida, Estados Unidos, 33140
- Mount Sinai Medical Center
-
Orlando, Florida, Estados Unidos, 32804
- Florida Hospital
-
Orlando, Florida, Estados Unidos, 32806
- Orlando Regional Medical Center
-
Palm Beach Gardens, Florida, Estados Unidos, 33410
- Palm Beach Gardens Research Center
-
Sarasota, Florida, Estados Unidos, 34233
- Velella Research
-
Tallahassee, Florida, Estados Unidos, 32308
- Tallahassee Research Institute, Inc.
-
West Palm Beach, Florida, Estados Unidos, 33401
- Cardiology Associates of Palm Beach - West Palm Beach
-
-
Georgia
-
Covington, Georgia, Estados Unidos, 30014
- Georgia Heart Specialist
-
Gainesville, Georgia, Estados Unidos, 30501
- Northeast Georgia Heart Center, P.C.
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60637
- University of Chicago
-
Chicago, Illinois, Estados Unidos, 60643
- Advocate Medical Group
-
Chicago, Illinois, Estados Unidos, 60657
- Advocate Medical Group - Heart and Vascular of IL
-
Melrose Park, Illinois, Estados Unidos, 60160
- Consultants in Cardiovascular Medicine
-
-
Indiana
-
Anderson, Indiana, Estados Unidos, 46011
- Community Heart and Vascular
-
-
Iowa
-
West Des Moines, Iowa, Estados Unidos, 50266
- Iowa Heart Center
-
-
Kansas
-
Kansas City, Kansas, Estados Unidos, 66160
- The University of Kansas
-
-
Kentucky
-
Lexington, Kentucky, Estados Unidos, 40503
- Baptist Health Lexington
-
-
Louisiana
-
Houma, Louisiana, Estados Unidos, 70363
- Leonard J. Chabert Medical Center
-
-
Maine
-
Auburn, Maine, Estados Unidos, 04210
- Maine Research Associates
-
Lewiston, Maine, Estados Unidos, 04240
- Maine Research Associates - Lewiston
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21201
- University of Maryland Medical Center
-
-
Massachusetts
-
Ayer, Massachusetts, Estados Unidos, 01432
- Primary Care Cardiology Research
-
Boston, Massachusetts, Estados Unidos, 02115
- Brigham and Women's Hospital
-
Fall River, Massachusetts, Estados Unidos, 02720
- NECCR Internal Medicine and Cardiology Associates, LLC
-
North Dartmouth, Massachusetts, Estados Unidos, 02747
- Hawthorn Medical Associates
-
Springfield, Massachusetts, Estados Unidos, 01199
- Baystate Cardiology
-
-
Michigan
-
Ann Arbor, Michigan, Estados Unidos, 48109
- University of Michigan Medical Center
-
Dearborn, Michigan, Estados Unidos, 48124
- Oakwood Hospital & Medical Center
-
Mount Clemens, Michigan, Estados Unidos, 48043
- McLaren Medical Center - Macomb
-
Ypsilanti, Michigan, Estados Unidos, 48197
- Michigan Heart
-
-
Minnesota
-
Minneapolis, Minnesota, Estados Unidos, 55417
- Minneapolis VA Medical Center
-
-
Missouri
-
Columbia, Missouri, Estados Unidos, 65201
- University of Missouri Health Care
-
-
Montana
-
Kalispell, Montana, Estados Unidos, 59901
- Glacier View Cardiology
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68131
- The Cardiac Center of Creighton University
-
-
New Jersey
-
Bridgewater, New Jersey, Estados Unidos, 08807
- Advanced Heartcare, LLC
-
Paterson, New Jersey, Estados Unidos, 07503
- St. Joseph Regional Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, Estados Unidos, 87108
- New Mexico VA Healthcare Systems
-
-
New York
-
Albany, New York, Estados Unidos, 12205
- Albany Associates Cardiology
-
Brooklyn, New York, Estados Unidos, 11219
- Maimonides Medical Center
-
Buffalo, New York, Estados Unidos, 14203
- Buffalo General Hospital/Kaleida Health
-
Jamaica, New York, Estados Unidos, 11418
- Jamaica Hospital Medical Center
-
Kingston, New York, Estados Unidos, 12401
- Mid-Valley Cardiology
-
Mineola, New York, Estados Unidos, 11501
- Winthrop-University Hospital
-
New York, New York, Estados Unidos, 10001
- Gotham Cardiovascular
-
New York, New York, Estados Unidos, 10032
- Columbia University Health Center
-
Stony Brook, New York, Estados Unidos, 11794
- Stony Brook University Medical Center
-
Utica, New York, Estados Unidos, 13501
- St. Elizabeth Medical Center - Hotvedt
-
-
North Carolina
-
Asheville, North Carolina, Estados Unidos, 28801
- Asheville Cardiology Associates
-
Elizabeth City, North Carolina, Estados Unidos, 27909
- Eastern Carolina Cardiovascular
-
Lenoir, North Carolina, Estados Unidos, 28645
- Northstate Clinical Research
-
Pinehurst, North Carolina, Estados Unidos, 28374
- Pinehurst Medical Clinic, Inc.
-
Sanford, North Carolina, Estados Unidos, 27330
- Sanford Cardiology
-
Winston-Salem, North Carolina, Estados Unidos, 27157
- Wake Forest
-
-
Ohio
-
Akron, Ohio, Estados Unidos, 44304
- Northeast Ohio Cardiovascular Specialists
-
Cincinnati, Ohio, Estados Unidos, 45267
- University of Cincinnati
-
Cleveland, Ohio, Estados Unidos, 44109
- MetroHealth Medical Center
-
Elyria, Ohio, Estados Unidos, 44035
- North Ohio Research, Ltd.
-
Fairfield, Ohio, Estados Unidos, 45014
- Mercy Medical Associates
-
Toledo, Ohio, Estados Unidos, 43615
- Northwest Ohio Cardiology Consultants/The Toledo Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73120
- Oklahoma Foundation for Cardiovascular Research
-
Oklahoma City, Oklahoma, Estados Unidos, 73104
- Oklahoma City VA Medical Center Veterans Research and Education Foundation
-
-
Pennsylvania
-
Abington, Pennsylvania, Estados Unidos, 19001
- Abington Memorial Hospital
-
Bethlehem, Pennsylvania, Estados Unidos, 18018
- St. Luke's Bethlehem
-
Doylestown, Pennsylvania, Estados Unidos, 18901
- Doylestown Cardiology Associates
-
Pittsburgh, Pennsylvania, Estados Unidos, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Estados Unidos, 15213
- University of Pittsburgh Medical Center
-
-
South Carolina
-
Anderson, South Carolina, Estados Unidos, 29621
- AnMed Health
-
Charleston, South Carolina, Estados Unidos, 29425
- VA Medical Center - Charleston
-
Rock Hill, South Carolina, Estados Unidos, 29732
- Carolina Cardiology Associates
-
-
South Dakota
-
Rapid City, South Dakota, Estados Unidos, 57701
- Black Hills Cardiovascular Research
-
-
Tennessee
-
Knoxville, Tennessee, Estados Unidos, 37917
- Cardiovasular Research of Knoxville
-
Memphis, Tennessee, Estados Unidos, 38104
- Memphis VA Medical Center
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- St. Luke's Episcopal Hospital
-
Houston, Texas, Estados Unidos, 77074
- Non-Invasive Cardiovascular PA
-
Waco, Texas, Estados Unidos, 76712
- Providence Health Center
-
-
Utah
-
Murray, Utah, Estados Unidos, 84157
- Intermountain Medical Center
-
-
Virginia
-
Virginia Beach, Virginia, Estados Unidos, 23454
- Cardiovascular Associates Virginia Beach
-
-
-
-
-
Rio Piedras, Puerto Rico, 00924
- Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Participants have been recruited throughout multicenter sites participating in the PRE-DETERMINE Cohort Study. Patients with a history of coronary artery disease and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%) have been enrolled. The clinical study staff at each site, which was either a research nurse, fellow, or physician approached eligible patients to discuss their potential participation.
Descripción
Inclusion Criteria:
-
Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.
-
LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.
-
If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.
-
Patients aged 18 years or above
-
CAD will be defined as evidence of one of the following two (2) criteria:
- Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography
- Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)
-
MI can be documented in the following ways:
-
From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:
- Symptoms of Ischemia
- ECG changes indicative of new ischemia (new ST-T changes or new LBBB)
- Development of pathological Q waves
- Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
-
If no report from the MI hospitalization is available, prior MI can be met by either of the following:
- Development of pathological Q waves
- Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause
-
-
Exclusion Criteria:
- History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).
- Unexplained syncope
- Current or planned implantable cardiac defibrillator (ICD)
- Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)
- Metastatic cancer
- Marked valvular heart disease requiring surgical intervention
- Current or planned cardiac, renal or liver transplant
- Current alcohol or drug abuse
- Unwilling or unable to provide informed consent
- LVEF <35% with Class II-IV CHF or LVEF <30%
- Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation.
Periodo de tiempo: Median follow-up estimated to be 10.7 years
|
A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation. |
Median follow-up estimated to be 10.7 years
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Implantación de DAI
Periodo de tiempo: Seguimiento medio estimado en 10,7 años
|
Seguimiento medio estimado en 10,7 años
|
|
|
Mortalidad cardíaca total
Periodo de tiempo: Seguimiento medio estimado en 10,7 años
|
Seguimiento medio estimado en 10,7 años
|
|
|
Mortalidad total
Periodo de tiempo: Seguimiento medio estimado en 10,7 años
|
Seguimiento medio estimado en 10,7 años
|
|
|
ICD Shock
Periodo de tiempo: Median follow-up estimated to be 10.7 years
|
ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint. |
Median follow-up estimated to be 10.7 years
|
|
Non-Sudden or Arrhythmic Causes of Mortality
Periodo de tiempo: Median follow-up estimated to be 10.7 years
|
Competing causes of mortality in competing risk analyses. |
Median follow-up estimated to be 10.7 years
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Christine M Albert, M.D., M.P.H., Brigham and Women's Hospital
Publicaciones y enlaces útiles
Publicaciones Generales
- Silverman MG, Yeri A, Moorthy MV, Camacho Garcia F, Chatterjee NA, Glinge CSA, Tfelt-Hansen J, Salvador AM, Pico AR, Shah R, Albert CM, Das S. Circulating miRNAs and Risk of Sudden Death in Patients With Coronary Heart Disease. JACC Clin Electrophysiol. 2020 Jan;6(1):70-79. doi: 10.1016/j.jacep.2019.08.011. Epub 2019 Oct 30.
- Lee DC, Albert CM, Narula D, Kadish AH, Panicker GK, Wu E, Schaechter A, Pester J, Chatterjee NA, Cook NR, Goldberger JJ. Estimating Myocardial Infarction Size With a Simple Electrocardiographic Marker Score. J Am Heart Assoc. 2020 Feb 4;9(3):e014205. doi: 10.1161/JAHA.119.014205. Epub 2020 Jan 24.
- Chatterjee NA, Tikkanen JT, Panicker GK, Narula D, Lee DC, Kentta T, Junttila JM, Cook NR, Kadish A, Goldberger JJ, Huikuri HV, Albert CM; PREDETERMINE Investigators. Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease. Eur Heart J. 2020 Jun 1;41(21):1988-1999. doi: 10.1093/eurheartj/ehaa177.
- Panicker GK, Narula DD, Albert CM, Lee DC, Kothari S, Goldberger JJ, Cook N, Schaechter A, Kim E, Moorthy MV, Pester J, Chatterjee NA, Kadish AH, Karnad DR. Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarction. Ann Noninvasive Electrocardiol. 2021 Mar;26(2):e12812. doi: 10.1111/anec.12812. Epub 2020 Oct 30.
- Venkateswaran RV, Moorthy MV, Chatterjee NA, Pester J, Kadish AH, Lee DC, Cook NR, Albert CM. Diabetes and Risk of Sudden Death in Coronary Artery Disease Patients Without Severe Systolic Dysfunction. JACC Clin Electrophysiol. 2021 Dec;7(12):1604-1614. doi: 10.1016/j.jacep.2021.05.014. Epub 2021 Jul 28.
- Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol. 2017 Jul 1;2(7):767-774. doi: 10.1001/jamacardio.2017.1413.
- Sandhu RK, Dron JS, Liu Y, Moorthy MV, Chatterjee NA, Ellinor PT, Chasman DI, Cook NR, Khera AV, Albert CM. Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function. J Am Coll Cardiol. 2022 Aug 30;80(9):873-883. doi: 10.1016/j.jacc.2022.05.049.
- Peek N, Hindricks G, Akbarov A, Tijssen JGP, Jenkins DA, Kapacee Z, Parkes LM, van der Geest RJ, Longato E, Sprague D, Taleb Y, Ong M, Miller CA, Shamloo AS, Albert C, Barthel P, Boveda S, Braunschweig F, Johansen JB, Cook N, de Chillou C, Elders P, Faxen J, Friede T, Fusini L, Gale CP, Jarkovsky J, Jouven X, Junttila J, Kautzner J, Kiviniemi A, Kutyifa V, Leclercq C, Lee DC, Leigh J, Lenarczyk R, Leyva F, Maeng M, Manca A, Marijon E, Marschall U, Merino JL, Mont L, Nielsen JC, Olsen T, Pester J, Pontone G, Roca I, Schmidt G, Schwartz PJ, Sticherling C, Suleiman M, Taborsky M, Tan HL, Tfelt-Hansen J, Thiele H, Tomaselli GF, Verstraelen T, Vinayagamoorthy M, Olesen KKW, Wilde A, Willems R, Wu KC, Zabel M, Martin GP, Dagres N. Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts. Eur Heart J. 2024 Nov 14;45(43):4616-4626. doi: 10.1093/eurheartj/ehae326.
- Chatterjee NA, Moorthy MV, Pester J, Schaecter A, Panicker GK, Narula D, Lee DC, Goldberger JJ, Kadish A, Cook NR, Albert CM; PRE-DETERMINE Study Group. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction. JAMA Cardiol. 2018 Jul 1;3(7):591-600. doi: 10.1001/jamacardio.2018.1049.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimado)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades Vasculares
- Enfermedades cardiovasculares
- Procesos Patológicos
- Enfermedades cardíacas
- Muerte
- Infarto
- Necrosis
- Disfunción ventricular
- Arteriosclerosis
- Enfermedades arteriales oclusivas
- Enfermedad coronaria
- Isquemia miocardica
- Isquemia
- Paro cardíaco
- Muerte Súbita
- Condiciones Patológicas, Signos y Síntomas
- Disfunción Ventricular Izquierda
- Enfermedad de la arteria coronaria
- Muerte Súbita Cardíaca
- Infarto de miocardio
Otros números de identificación del estudio
- 2007P000840
- R01HL091069 (Subvención/contrato del NIH de EE. UU.)
- R01HL165840 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .